ClinicalTrials.Veeva

Menu

Metabolomics in Occupational Asthma

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Enrolling

Conditions

Asthma, Occupational

Treatments

Device: Breath Biopsy

Study type

Observational

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • capable of informed consent.
  • asthma diagnosis established by lung specialist or healthy control.

Exclusion criteria

  • skin allergy towards plastics or rubber.
  • immunocompromised by oral medication.
  • contagious respiratory disease.
  • biopsy of lung parenchyma within the last 36 hours.

Trial design

80 participants in 2 patient groups

Occupational Asthma
Description:
Patients refered for assesment of occupational asthma
Treatment:
Device: Breath Biopsy
Respiratory Healthy Control
Description:
Employees at Oslo University Hospital
Treatment:
Device: Breath Biopsy

Trial contacts and locations

1

Loading...

Central trial contact

Bato Hammarström, MD/PhD; Tonje Trulssen Hildre, M.Sc.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems